Citigroup
OFIX icon

Citigroup’s Orthofix Medical OFIX Stock Holding History

Citigroup’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$245K Buy
21,371
+943
+5% +$12.5K ﹤0.01% 3916
2025
Q4 		$310K Sell
20,428
-20,177
-50% -$308K ﹤0.01% 3803
2025
Q3 		$594K Buy
40,605
+25,615
+171% +$336K ﹤0.01% 3491
2025
Q2 		$167K Sell
14,990
-12,599
-46% -$156K ﹤0.01% 4149
2025
Q1 		$450K Sell
27,589
-1,054
-4% -$18.5K ﹤0.01% 3738
2024
Q4 		$500K Buy
28,643
+3,484
+14% +$60.6K ﹤0.01% 3828
2024
Q3 		$393K Buy
25,159
+17,117
+213% +$274K ﹤0.01% 3880
2024
Q2 		$107K Sell
8,042
-791
-9% -$10.8K ﹤0.01% 4177
2024
Q1 		$128K Buy
8,833
+2,863
+48% +$39.6K ﹤0.01% 4194
2023
Q4 		$80.5K Sell
5,970
-8,069
-57% -$94.8K ﹤0.01% 4294
2023
Q3 		$181K Sell
14,039
-11,188
-44% -$201K ﹤0.01% 3700
2023
Q2 		$456K Buy
25,227
+9,551
+61% +$178K ﹤0.01% 3440
2023
Q1 		$263K Buy
15,676
+198
+1% +$3.88K ﹤0.01% 3567
2022
Q4 		$318K Buy
15,478
+1,656
+12% +$29.2K ﹤0.01% 3476
2022
Q3 		$264K Buy
13,822
+2,208
+19% +$49.6K ﹤0.01% 3635
2022
Q2 		$273K Sell
11,614
-7,611
-40% -$218K ﹤0.01% 3657
2022
Q1 		$629K Buy
19,225
+1,165
+6% +$37.4K ﹤0.01% 3349
2021
Q4 		$561K Buy
18,060
+4,686
+35% +$157K ﹤0.01% 3706
2021
Q3 		$510K Buy
13,374
+2,318
+21% +$92.3K ﹤0.01% 3591
2021
Q2 		$443K Buy
11,056
+8,582
+347% +$363K ﹤0.01% 3785
2021
Q1 		$107K Sell
2,474
-2,741
-53% -$121K ﹤0.01% 4327
2020
Q4 		$224K Buy
5,215
+3,490
+202% +$127K ﹤0.01% 4901
2020
Q3 		$54K Sell
1,725
-7,067
-80% -$219K ﹤0.01% 5545
2020
Q2 		$281K Buy
8,792
+2,773
+46% +$92K ﹤0.01% 4750
2020
Q1 		$169K Sell
6,019
-2,813
-32% -$109K ﹤0.01% 4870
2019
Q4 		$408K Sell
8,832
-6,221
-41% -$292K ﹤0.01% 4604
2019
Q3 		$798K Buy
15,053
+5,570
+59% +$287K ﹤0.01% 3882
2019
Q2 		$501K Sell
9,483
-7,173
-43% -$382K ﹤0.01% 4428
2019
Q1 		$939K Buy
16,656
+8,413
+102% +$472K ﹤0.01% 3480
2018
Q4 		$432K Sell
8,243
-12,722
-61% -$724K ﹤0.01% 4289
2018
Q3 		$1.21M Buy
20,965
+8,654
+70% +$485K ﹤0.01% 3272
2018
Q2 		$700K Buy
12,311
+2,908
+31% +$166K ﹤0.01% 3732
2018
Q1 		$553K Sell
9,403
-4,449
-32% -$249K ﹤0.01% 3878
2017
Q4 		$758K Sell
13,852
-17,281
-56% -$896K ﹤0.01% 3632
2017
Q3 		$1.47M Sell
31,133
-23,228
-43% -$1.09M ﹤0.01% 2974
2017
Q2 		$2.53M Buy
54,361
+30,565
+128% +$1.27M ﹤0.01% 2354
2017
Q1 		$908K Buy
23,796
+1,082
+5% +$40.1K ﹤0.01% 3326
2016
Q4 		$822K Buy
22,714
+15,585
+219% +$592K ﹤0.01% 3890
2016
Q3 		$305K Buy
7,129
+4,601
+182% +$205K ﹤0.01% 4336
2016
Q2 		$107K Sell
2,528
-69,851
-97% -$3.04M ﹤0.01% 5023
2016
Q1 		$3M Buy
72,379
+66,478
+1,127% +$2.61M ﹤0.01% 2061
2015
Q4 		$231K Buy
5,901
+5,898
+196,600% +$220K ﹤0.01% 4608
2015
Q3 		$0 Sell
3
-247
-99% -$8.79K ﹤0.01% 7611
2015
Q2 		$8K Sell
250
-1,560
-86% -$53.6K ﹤0.01% 6569
2015
Q1 		$65K Sell
1,810
-1,507
-45% -$47.4K ﹤0.01% 5359
2014
Q4 		$99K Sell
3,317
-773
-19% -$22.7K ﹤0.01% 5234
2014
Q3 		$127K Buy
4,090
+459
+13% +$15.2K ﹤0.01% 4560
2014
Q2 		$132K Sell
3,631
-3,638
-50% -$118K ﹤0.01% 4459
2014
Q1 		$219K Sell
7,269
-11,798
-62% -$272K ﹤0.01% 4239
2013
Q4 		$435K Buy
19,067
+15,512
+436% +$324K ﹤0.01% 3928
2013
Q3 		$74K Sell
3,555
-4,912
-58% -$119K ﹤0.01% 4965
2013
Q2 		$228K Buy
+8,467
New +$254K ﹤0.01% 4164

Other funds holding OFIX

ECM
Engine Capital Management New York $828M AUM 6.49% 1-Year Est. Return
JIC
Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citigroup's OFIX Position: Q1 2026 in Review

Citigroup increased its Orthofix Medical (OFIX) stake by 4.6% in Q1 2026, buying an estimated $12.5K and bringing the position to 21,371 shares worth $245K. The position accounts for ﹤0.01% of the portfolio, ranked #3916.

Citigroup first reported a position in OFIX in Q2 2013 and has held it in 52 quarters since. The position peaked at $3M in Q1 2016. 147 funds tracked by Wall St. Rank hold OFIX as of Q1 2026.

  • Citigroup held 21,371 shares of Orthofix Medical worth $245K as of Q1 2026.
  • Citigroup bought 943 Orthofix Medical shares in Q1 2026, an estimated $12.5K.
  • Orthofix Medical made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #3916 holding.
  • Citigroup first reported a position in Orthofix Medical in Q2 2013 and has held it in 52 quarters since.
  • Citigroup's Orthofix Medical position peaked at $3M in Q1 2016.
  • 147 funds tracked by Wall St. Rank held Orthofix Medical as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.